Skip to content

NACI recommends universal immunization program against RSV for infants

The National Advisory Committee on Immunization is recommending a universal immunization program against respiratory syncytial virus, or RSV, for all infants.
20240517150528-1c1e6e14f8ad30d4ca1320fe738572c239c3564dea3f7b726a2256857d47955d
The National Advisory Committee on Immunization is recommending a universal immunization program against respiratory syncytial virus, or RSV, for all infants. This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV) virions, colourized blue, and anti-RSV F protein/gold antibodies, colourized yellow, shedding from the surface of human lung cells. THE CANADIAN PRESS/AP-HO, NIH, National Institute of Allergy and Infectious Diseases, *MANDATORY CREDIT*

The National Advisory Committee on Immunization is recommending a universal immunization program against respiratory syncytial virus, or RSV, for all infants.   

It says provinces and territories should work toward providing the antibody drug Nirsevimab for all infants before their first RSV season. 

But it says they could start by prioritizing the highest-risk infants if cost or access to the antibody is a barrier to implementing a universal program right away.  

Babies at highest risk of becoming seriously ill with RSV include those born prematurely, those with certain medical conditions and infants living in crowded conditions or other high-risk settings.   

The committee says Nirsevimab should also be prioritized for infants living in remote areas where transportation to get treatment would be difficult if they got severe RSV, including some First Nations, Métis and Inuit communities. 

Health Canada authorized Nirsevimab — also known by its brand name Beyfortus — in April 2023. 

The national committee also said that pregnant people and their health-care providers could consider a vaccine called RSVpreF, or Abrysvo, which is given during the third trimester to provide protection against RSV for the infant.  

This report by The Canadian Press was first published May 17, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

Nicole Ireland, The Canadian Press

push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks